Human Plasma VLDL Native

<strong>Human Plasma VLDL Native</strong>_x000D_ <strong>Catalog number:</strong> B2016956_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 10,000 kDa - 80,000 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> Very low density lipoprotein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Safar JG, Wille H, Geschwind MD, Deering C, Latawiec D, Serban A, King DJ, Legname G, Weisgraber KH, Mahley RW, Miller BL, Dearmond SJ, Prusiner SB. Human prions and plasma lipoproteins Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11312-7._x000D_ 2: Massey JB, Pownall HJ. Surface properties of native human plasma lipoproteins and lipoprotein models Biophys J. 1998 Feb;74(2 Pt 1):869-78._x000D_ 3: Chappell DA, Medh JD. Receptor-mediated mechanisms of lipoprotein remnant catabolism Prog Lipid Res. 1998 Dec;37(6):393-422._x000D_ 4: Ranganathan S, Matsuura H, Yamamoto M, Kottke BA. Metabolism of apolipoprotein E-containing human plasma lipoproteins by rat and human cells in culture Biochem J. 1986 Nov 15;240(1):125-30._x000D_ 5: Keidar S, Kaplan M, Rosenblat M, Brook GJ, Aviram M. Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized very-low-density lipoprotein (VLDL), but increase cellular degradation of native VLDL Metabolism. 1992 Nov;41(11):1185-92._x000D_ 6: Howard BV. Diabetes and plasma lipoproteins in Native Americans. Studies of the Pima Indians Diabetes Care. 1993 Jan;16(1):284-91._x000D_ 7: Dergunov AD, Vorotnikova YY. The interaction of human serum albumin in the native and fully reduced states with apolipoprotein E, serum amyloid protein and very low density lipoproteins from human plasma Int J Biochem. 1994 Jul;26(7):933-42._x000D_ 8: Tsao BP, Curtiss LK, Edgington TS. Immunochemical heterogeneity of human plasma apolipoprotein B. II. Expression of apolipoprotein B epitopes on native lipoproteins J Biol Chem. 1982 Dec 25;257(24):15222-8._x000D_ 9: Tertov VV, Kaplun VV, Sobenin IA, Boytsova EY, Bovin NV, Orekhov AN. Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein Atherosclerosis. 2001 Nov;159(1):103-15._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/9409200">10: Calvo D, Gómez-Coronado D, Lasunción MA, Vega MA. CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2341-9. </a>_x000D_ _x000D_ <strong>Products Related to Human Plasma VLDL Native can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>